[go: up one dir, main page]

MX2015009364A - Uso de sales de tungsteno (vi) para el tratamiento de infertilidad femenina en mamiferos no diabeticos. - Google Patents

Uso de sales de tungsteno (vi) para el tratamiento de infertilidad femenina en mamiferos no diabeticos.

Info

Publication number
MX2015009364A
MX2015009364A MX2015009364A MX2015009364A MX2015009364A MX 2015009364 A MX2015009364 A MX 2015009364A MX 2015009364 A MX2015009364 A MX 2015009364A MX 2015009364 A MX2015009364 A MX 2015009364A MX 2015009364 A MX2015009364 A MX 2015009364A
Authority
MX
Mexico
Prior art keywords
treatment
female infertility
tungsten salts
diabetic mammals
mammals
Prior art date
Application number
MX2015009364A
Other languages
English (en)
Other versions
MX356851B (es
Inventor
Ignacio Canals Almazán
Agnès Arbat Bugié
Original Assignee
Oxolife Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49999950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2015009364(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Oxolife Sl filed Critical Oxolife Sl
Publication of MX2015009364A publication Critical patent/MX2015009364A/es
Publication of MX356851B publication Critical patent/MX356851B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physiology (AREA)

Abstract

La invención actual comprende el uso de una cantidad terapéuticamente efectiva de una sal de tungsteno (VI) con un grupo catiónico farmacéuticamente o veterinariamente aceptable, o un solvato de la sal, para la preparación de un producto medicinal para el tratamiento de infertilidad femenina en mamíferos no diabéticos.
MX2015009364A 2013-01-22 2014-01-21 Uso de sales de tungsteno (vi) para el tratamiento de infertilidad femenina en mamiferos no diabeticos. MX356851B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES201330071A ES2478790B1 (es) 2013-01-22 2013-01-22 Uso de sales de tungsteno (VI) para el tratamiento de la infertilidad femenina en mamíferos no diabéticos
PCT/EP2014/051141 WO2014114644A1 (en) 2013-01-22 2014-01-21 Use of tungsten (vi) salts for the treatment of female infertility in non-diabetic mammals

Publications (2)

Publication Number Publication Date
MX2015009364A true MX2015009364A (es) 2016-03-08
MX356851B MX356851B (es) 2018-06-18

Family

ID=49999950

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009364A MX356851B (es) 2013-01-22 2014-01-21 Uso de sales de tungsteno (vi) para el tratamiento de infertilidad femenina en mamiferos no diabeticos.

Country Status (26)

Country Link
US (1) US9675638B2 (es)
EP (1) EP2948156B1 (es)
JP (1) JP6045721B2 (es)
KR (1) KR102182563B1 (es)
CN (1) CN105188721B (es)
AU (1) AU2014209987B2 (es)
BR (1) BR112015017483A2 (es)
CA (1) CA2898953C (es)
CL (1) CL2015002047A1 (es)
CY (1) CY1118287T1 (es)
DK (1) DK2948156T3 (es)
ES (2) ES2478790B1 (es)
HR (1) HRP20161611T1 (es)
HU (1) HUE031910T2 (es)
IL (1) IL240062B (es)
LT (1) LT2948156T (es)
MX (1) MX356851B (es)
NZ (1) NZ710583A (es)
PL (1) PL2948156T3 (es)
PT (1) PT2948156T (es)
RS (1) RS55418B1 (es)
RU (1) RU2635507C2 (es)
SG (1) SG11201505701WA (es)
SI (1) SI2948156T1 (es)
SM (2) SMT201700018T1 (es)
WO (1) WO2014114644A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2639588B1 (es) * 2014-05-21 2018-09-06 Oxolife, S.L. Uso de una sal de tungsteno (VI) para favorecer la fertilidad y la reproducción normal en un mamífero hembra no diabético
ES2551828B1 (es) * 2014-05-21 2016-09-12 Oxolife S.L. Composiciones alimentarias que comprenden sales de tungsteno (VI)
CA2955914C (en) * 2014-07-21 2022-09-06 Ignacio Canals Almazan Tungsten (vi) salts for use thereof in the treatment of infertility, for favoring normal reproduction and fertility in a non-diabetic female mammal, as well as for improving the efficacy of assisted reproductive techniques
EP4368577A1 (en) * 2022-11-08 2024-05-15 Oxolife, S.L. Process for the preparation of tungsten (vi) salt hydrates
WO2026008874A1 (en) 2024-07-05 2026-01-08 Oxolife, S.L. Tungsten (vi) salts for use for increasing ongoing pregnancies, for increasing live birth rates and/or for increasing the biochemical pregnancy rate in infertile women

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
ES2108642B1 (es) * 1995-07-26 1998-08-16 Quimica Farm Bayer Sa Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.
RU2141361C1 (ru) * 1998-03-12 1999-11-20 Пермская государственная медицинская академия Способ лечения ановуляторного бесплодия при ожирении
ES2187276B1 (es) * 2001-05-16 2004-08-01 Quimica Farmaceutica Bayer,S.A. Composiciones orales para el tratamiento de humanos obesos y no diabeticos.
CA2500897A1 (en) * 2002-10-02 2004-04-15 Yeda Research And Development Co. Ltd. Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
RU2270684C1 (ru) * 2005-01-20 2006-02-27 Анатолий Григорьевич Гриценко Лекарственный препарат "витасорб"
US20080206356A1 (en) * 2005-07-29 2008-08-28 Universidad De Barcelona Pharmaceutical Compositions for the Treatment of Neurodegenerative Disorders
US20060100154A1 (en) * 2005-10-13 2006-05-11 Yeda Research And Development Co Long-acting gonadotropin-releasing hormone analogs and methods of use thereof

Also Published As

Publication number Publication date
EP2948156A1 (en) 2015-12-02
US20150359820A1 (en) 2015-12-17
IL240062A0 (en) 2015-09-24
JP6045721B2 (ja) 2016-12-14
HK1217442A1 (en) 2017-01-13
HUE031910T2 (en) 2017-08-28
PL2948156T3 (pl) 2017-07-31
WO2014114644A1 (en) 2014-07-31
SMT201700018B (it) 2017-03-08
RU2015135578A (ru) 2017-03-02
CN105188721A (zh) 2015-12-23
CL2015002047A1 (es) 2016-01-04
AU2014209987A1 (en) 2016-01-21
US9675638B2 (en) 2017-06-13
AU2014209987B2 (en) 2016-09-01
RS55418B1 (sr) 2017-04-28
CA2898953A1 (en) 2014-07-31
SMT201700018T1 (it) 2017-03-08
ES2478790B1 (es) 2015-05-06
LT2948156T (lt) 2016-12-27
NZ710583A (en) 2016-06-24
IL240062B (en) 2018-11-29
HRP20161611T1 (hr) 2017-01-27
JP2016505057A (ja) 2016-02-18
SG11201505701WA (en) 2015-08-28
CY1118287T1 (el) 2017-06-28
EP2948156B1 (en) 2016-10-26
BR112015017483A2 (pt) 2017-07-11
ES2611776T3 (es) 2017-05-10
ES2478790A1 (es) 2014-07-22
KR20150130992A (ko) 2015-11-24
DK2948156T3 (da) 2017-01-02
CN105188721B (zh) 2017-10-31
SI2948156T1 (sl) 2017-02-28
KR102182563B1 (ko) 2020-11-25
MX356851B (es) 2018-06-18
PT2948156T (pt) 2016-11-30
CA2898953C (en) 2018-01-02
RU2635507C2 (ru) 2017-11-13

Similar Documents

Publication Publication Date Title
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
UY37505A (es) Conjugados que comprenden un agonista dual de glp-1/glucagón, un conector y ácido hialurónico
PH12018502742A1 (en) Glucagon derivative, conjugate thereof, composition comprising same and therapeutic use thereof
SV2015005115A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
CO7310528A2 (es) Composición farmacéutica recubierta que contiene regorafenib
CL2014001049A1 (es) Compuestos derivados de purina sustituida, inhibidores de mtor; composicion farmaceutica; combinacion farmaceutica; uso para el tratamiento o prevencion del cancer, un trastorno neurodegenerativo o una enfermedad oftalmologica.
CL2014000543A1 (es) Compuestos derivados de imidazopiridazinas sustituidas con amino, inhibidores de la quinasa ,mknk2; metodo de preparacion; compuestos intermediarios y su uso; composicion farmaceutica; combinacion farmaceutica; y su uso para el tratamiento del cancer.
AR090491A1 (es) Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fumarato de dimetilo
CY1119798T1 (el) Μορφη iv υδροχλωρικης ιβαμπραδινης
CL2016001756A1 (es) Preparación farmacéutica que comprende 0,001-0,003 pv de 6-4-pirazol-1-ilbencilpiridin-3-ilsulfonilaminometilpiridin-2-ilaminoacetato de isopropilo o una sal del mismo uso para el tratamiento o prevención de glaucoma o hipertensión ocular.
UY35359A (es) 7-OXO-PIRIDO[2,3-d]PIRIMIDINAS SUSTITUIDAS Y MÉTODOS DE USO
AR085616A1 (es) Composicion farmaceutica inhalable que comprende glicopirrolato, uso
PH12016500985A1 (en) Use of benzimidazole-proline derivatives
MX2016011105A (es) Inhibidores de monoacilglicerol aciltransferasa 2 (mgat2) de dihidropiridinona para usarse en el tratamiento de trastornos metabolicos.
MX2015009364A (es) Uso de sales de tungsteno (vi) para el tratamiento de infertilidad femenina en mamiferos no diabeticos.
EA201691741A1 (ru) Фармацевтическая композиция
AR094241A1 (es) Ciclesonida para el tratamiento de la enfermedad de las vias respiratorias en caballos
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
MX386902B (es) Metodos para el tratamiento de trastornos cardiovasculares.
PH12018501991A1 (en) Pharmaceutical composition for use in treating fibrosis
WO2019203748A3 (en) The composition comprising raloxifene with at least one antipsychotic agent
PH12017501982A1 (en) Pharmaceutical compound
AR109209A1 (es) Composición farmacéutica para prevención o tratamiento de enfermedades neurodegenerativas
AR134057A2 (es) Composición farmacéutica en solución acuosa

Legal Events

Date Code Title Description
FG Grant or registration